Patient Outcomes AI in Medicine Cancer Treatment Drug Development Randomized Controlled Trials Antidepressants Gene Therapy Trials Weight Loss Drugs Drug Safety Trials Approval Process Pre-Clinical Trials Drug Development Stages Neurological Diseases Mental Health Cardiovascular Diseases Addiction Self-Testing Trials Animal Studies Pharmaceuticals Screening Methods Transplant Research Research Tools Mitochondrial Disease Research Endoscopic Procedures Hormonal Therapies Primate Research CAR T-cell Therapy Alzheimer's Disease Stem Cell Therapy Mitochondrial Donation Cell Therapy Psychedelic Therapy Brain Cancer Clinical Trials Placebo Effect ADPKD Clinical Trials Effectiveness of Weight Loss Medications Drug Trials Phase II Trials Treatment Innovations Psychiatric Disorders HIV Aural Toileting Fertility Research Pregnancy Loss Treatments Preventive Medicine Alzheimer's Disease Research Surgical Interventions Antihypertensive Drugs mRNA Technology Therapies Cystic Fibrosis Funding Challenges Immune System Disorders Experimental Treatments AI Applications in Medicine DFMO Treatment Phase 1/2 Studies Preclinical Studies Patient Studies Phase 2 Trials Biomarkers Gene Therapy Type 2 Diabetes Pregnancy Complications Therapeutic Approaches Stroke Prevention Innovative Treatments Cancer Research Vaccine Trials Male Contraceptive Trials Contraceptive Trials
Stronger sales of newer cancer and immune therapies offset the Stelara decline, supporting a higher full-year view despite pricing concessions.
